4//SEC Filing
Lebwohl David 4
Accession 0001193125-26-006283
CIK 0001652130other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:04 PM ET
Size
5.0 KB
Accession
0001193125-26-006283
Insider Transaction Report
Form 4
Lebwohl David
EVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2026-01-05$9.21/sh−11,903$109,627→ 121,249 total
Footnotes (2)
- [F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.
- [F2]Includes 1,022 and 1,264 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2025 and December 31, 2025, respectively.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001810882
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:04 PM ET
- Size
- 5.0 KB